Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.
ATMP specialist Cobra Biologics builds Sweden’s first 500 litre bioreactor investing €20 million at its Matfors facility in Sundsvall.
Earlier this year, BioInsights hosted an expert roundtable featuring Dr Clive Glover (Pall), Dr Damian Marshall (Cell and Gene Therapy Catapult) and Cobra's CSO, Dr Daniel Smith to discuss providing innovation to viral vector bioprocessing if AAV vector supply is to meet increasing demand.
We are in full preparation for the BioEurope spring in Wienna taking place 25th to 27th March.
Lund company Bionamic and researchers from Lund University shared first place with another team in a challenge arranged by the US Food and Drug Administration (FDA), and the National Cancer Institute (NCI). Their AI-based computer model achieved 100 percent success in detecting and correcting mislabeled analysis results from tumor biopsies in a complex dataset. The prize is, partly, to publish an article about the work in the science paper Nature Medicine.
Cobra Biologics (“Cobra”) a leading international contract development and manufacturing organisation (“CDMO”) were presented with the Queen’s Award for Enterprise in International Trade 2018, by the Lord Lieutenant of Staffordshire on 20 September 2018.
Cobra Biologics (Cobra), an international contract development and manufacturing organisation (CDMO) of biologics and pharmaceuticals, today announced a collaboration with the Centre for Process Innovation (CPI), a UK-based technology innovation centre and GE Healthcare Life Sciences.